Keryx Biopharmaceuticals, Inc.

(NASDAQ:KERX)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 6,779 14,037 5,774 19,065
Restricted Cash — — — —
Marketable Securities 10,305 10,325 20,838 43,038
Accounts Receivable — — — —
Loans Receivable — — — —
Other Receivable 222 99 8,463 283
Receivables 222 99 8,463 283
Raw Materials — — — —
Work in Progress — — — —
Purchased Components — — — —
Finished Goods — — — —
Other Inventories — — — —
Inventories Adjustments and Allowances — — — —
Inventories — — — —
Prepaid Expenses — — — —
Current Deferred Income Taxes — — — —
Other Current Assets 684 1,201 1,616 1,330
Total Current Assets 17,990 25,662 36,691 63,716
Land and Improvements — — — —
Building and Improvements — — — 36
Machinery Furniture and Equipment — — — 11,949
Construction in Progress — — — —
Other Fixed Assets 696 742 776 —
Total Fixed Assets 696 742 776 11,985
Gross Fixed Assets 696 742 776 11,985
Accumulated Depreciation and Depletion 488 488 488 488
Net Fixed Assets 208 254 288 11,497
Intangibles — — — —
Cost in Excess 3,208 3,208 3,208 3,208
Non Current Deferred Income Taxes — — — —
Other Non Current Assets 9,296 10,227 12,588 2,640
Total Non Current Assets 12,712 13,689 16,084 17,345
Total Assets 30,702 39,351 52,775 81,061
Liabilities
Current Liabilities
Accounts Payable 6,005 9,704 16,787 19,134
Notes Payable — — — —
Short Term Debt — — — —
Accrued Expenses — — — —
Accrued Liabilities 1,018 864 1,114 1,254
Deferred Revenues 1,464 1,495 1,557 1,023
Current Deferred Income Tax Liabilities — — — —
Other Current Liabilities 120 — — —
Total Current Liabilities 8,607 12,063 19,458 21,411
Non Current Liabilities
Long Term Debt — — — —
Capital Lease Obligations — — — —
Deferred Income Tax Liabilities — — — —
Other Non Current Liabilities 21,774 22,122 22,472 15,228
Minority Interest Liabilities — — — —
Preferred Securities of Subsidiary Trust Liabilities — — — —
Preferred Equity Outside Stock Equity — — — —
Total Non Current Liabilities 30,381 34,185 41,930 36,639
Total Liabilities 21,774 22,122 22,472 15,228
Shareholders' Equity
Preferred Stock Equity — — — —
Common Stock Equity 321 5,166 10,845 44,422
Common Par 45 45 44 44
Additional Paid in Capital 327,981 325,985 323,968 323,009
Cumulative Translation Adjustment — — — —
Retained Earnings -327,348 -320,507 -312,810 -278,274
Treasury Stock -357 -357 -357 -357
Other Equity Adjustments — — — —
Total Capitalization 321 5,166 10,845 44,422
Cash Flow -78,215 -90,886 -102,648 -89,911
Working Capital 9,383 13,599 17,233 42,305
Free Cash Flow -35,537 -28,259 -23,713 -60,704
Invested Capital 321 5,166 10,845 44,422
Total Equity 321 5,166 10,845 44,422
Total Liabilities and Stock Equity 30,702 39,351 52,775 81,061